Patents by Inventor James Alexander Campbell

James Alexander Campbell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Insulin sensitisers and methods of treatment
    Patent number: 10172837
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitizers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: January 8, 2019
    Assignee: Naia Metabolic, Inc.
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, James Alexander Campbell, Juan-Carlos Molero-Navajas, Nicky Konstantopoulos, Guy Yeoman Krippner
  • INSULIN SENSITISERS AND METHODS OF TREATMENT
    Publication number: 20170079960
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitisers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Application
    Filed: September 26, 2016
    Publication date: March 23, 2017
    Inventors: Gregory Royce COLLIER, Kenneth Russell WALDER, James Alexander CAMPBELL, Juan-Carlos MOLERO-NAVAJAS, Nicky KONSTANTOPOULOS, Guy Yeoman KRIPPNER
  • Insulin sensitisers and methods of treatment
    Patent number: 9452148
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitizers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: September 27, 2016
    Assignee: Verva Pharmaceuticals Ltd
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, James Alexander Campbell, Juan-Carlos Molero-Navajas, Nicky Konstantopoulos, Guy Yeoman Krippner
  • INSULIN SENSITISERS AND METHODS OF TREATMENT
    Publication number: 20140011848
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitisers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Application
    Filed: May 31, 2013
    Publication date: January 9, 2014
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, James Alexander Campbell, Juan-Carlos Molero-Navajas, Nicky Konstantopoulos, Guy Yeoman Krippner
  • Insulin sensitisers and methods of treatment
    Patent number: 8455432
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitizers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: June 4, 2013
    Assignee: Verva Pharmaceuticals Ltd.
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, James Alexander Campbell, Juan-Carlos Molero-Navajas, Nicky Konstantopoulos, Guy Yeoman Krippner
  • Systems And Methods For Secure Network Interoperability and Management
    Publication number: 20110302629
    Abstract: The invention relates to an interoperability system that provides increased security and data tracking to security intensive applications, such as transportation systems that currently utilize a large number of independent devices and related systems.
    Type: Application
    Filed: January 5, 2011
    Publication date: December 8, 2011
    Inventors: Andrea L. Whitson, James Michael Teal, Dale Carruth, Thomas James Alexander Campbell
  • INSULIN SENSITISERS AND METHODS OF TREATMENT
    Publication number: 20110003740
    Abstract: The present invention relates generally to the field of therapy. The invention particularly relates to insulin sensitisers and methods of regulating glucose homeostasis and to the therapeutic or prophylactic treatment of diseases and associated conditions, in which impaired glucose uptake due to insulin resistance is involved or implicated, such as diabetes, syndrome X, hyperglycaemia, vascular disease and kidney disease. The present invention further relates to compounds and agents and compositions thereof for use in the treatment methods.
    Type: Application
    Filed: January 25, 2008
    Publication date: January 6, 2011
    Applicant: VERVA PHARMACEUTICALS LTD.
    Inventors: Gregory Royce Collier, Kenneth Russell Walder, James Alexander Campbell, Juan-Carlos Molero-Navajas, Nicky Konstantopoulos, Guy Yeoman Krippner